Suppr超能文献

猫苍白球连合部下的多巴胺D1受体及其在口面部运动障碍中的作用。

Dopamine D1 receptors in the sub-commissural part of the globus pallidus and their role in oro-facial dyskinesia in cats.

作者信息

Spooren W P, Piosik P A, Cools A R

机构信息

Department of Pharmacology, University of Nijmegen, The Netherlands.

出版信息

Eur J Pharmacol. 1991 Nov 5;204(2):217-22. doi: 10.1016/0014-2999(91)90708-x.

Abstract

The possible role of dopamine D1 receptors in the sub-commissural part of the globus pallidus in the induction of oro-facial dyskinesia was studied in cats. The present study reveals two findings. Firstly, bilateral injections of the D1 agonist (+/-)-SK& F38393 into the ventral pallidal area elicited oro-facial dyskinesia, which was quantified in terms of numbers of tongue protrusions. The results show that the dose-effect curve was bell-shaped (1.0, 1.75, 2.5, 5.0 micrograms/0.5 microliters (+/-)-SK&F38393). The oro-facial dyskinesia elicited by (+/-)-SK&F38393 was highly comparable to the oro-facial dyskinesia elicited by injections of the GABA antagonist picrotoxin or the acetylcholine agonist carbachol into the sub-commissural part of the globus pallidus. Secondly, the inactive enantiomer of SK&F38393, i.e. S(-)-SK&F38393, was found to be ineffective in eliciting oro-facial dyskinesia when injected in a dose equivalent to 50% of the most effective dose of the racemic mixture of (+/-)-SK&F38393. Furthermore, the effect elicited by 2.5 micrograms/0.5 microliters (+/-)-SK&F38393 was significantly attenuated by local injection of the D1 antagonist R(+)-SCH23390 in a dose which had no effect itself (1.0 micrograms/0.5 microliters). These findings indicate that the effects elicited by (+/-)-SK&F38393 are D1-specific. The present results thus clearly indicate that dopamine D1 receptors within the sub-commissural part of the globus pallidus are involved in mediating oro-facial dyskinesia in cats.

摘要

在猫身上研究了多巴胺D1受体在苍白球联合部下部分诱发口面部运动障碍中的可能作用。本研究揭示了两个发现。首先,向腹侧苍白球区域双侧注射D1激动剂(±)-SK&F38393会诱发口面部运动障碍,这通过伸舌次数进行量化。结果显示剂量效应曲线呈钟形(1.0、1.75、2.5、5.0微克/0.5微升(±)-SK&F38393)。(±)-SK&F38393诱发的口面部运动障碍与向苍白球联合部下部分注射GABA拮抗剂印防己毒素或乙酰胆碱激动剂卡巴胆碱所诱发的口面部运动障碍高度相似。其次,发现SK&F38393的无活性对映体,即S(-)-SK&F38393,以相当于(±)-SK&F38393外消旋混合物最有效剂量50%的剂量注射时,在诱发口面部运动障碍方面无效。此外,局部注射本身无效剂量(1.0微克/0.5微升)的D1拮抗剂R(+)-SCH23390可显著减弱2.5微克/0.5微升(±)-SK&F38393所产生的效应。这些发现表明(±)-SK&F38393所产生的效应具有D1特异性。因此,目前的结果清楚地表明苍白球联合部下部分的多巴胺D1受体参与介导猫的口面部运动障碍。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验